FDA Warns: Bextra ( valdexocib ) Health Danger

FDA Wants Bextra Withdrawn from Market The Food and Drug Administration (FDA) today announced a series of important changes pertaining to the marketing of the non-steroidal anti-inflammatory class of drugs, including COX-2 selective and prescription and non-prescription (over-the-counter (OTC)) non-selective NSAID medications. OTC, COX-2, NSAID Danger List. “Today’s actions protect and advance the health of…

FDA Warns: Stop selling Levothyroid

FDA Warns: Stop selling Levothyroid The U.S. Food and Drug Administration has sent a warning to Forest Laboratories Inc. for failing to obtain approval for thyroid drug Levothyroid and told the company to stop marketing it, according to a letter released on August 19, 2003. Levothyroid is a drug used for thyroid hormone replacement therapy.…